• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比利时公私混合的医疗保健系统及其对终末期肾病治疗费用的影响。

Belgium's mixed private/public health care system and its impact on the cost of end-stage renal disease.

作者信息

Van Biesen Wim, Lameire Norbert, Peeters Patrick, Vanholder Raymond

机构信息

Renal Division, Department of Internal Medicine, University Hospital Ghent, De Pintelaan 185, 9000 Ghent, Belgium.

出版信息

Int J Health Care Finance Econ. 2007 Sep;7(2-3):133-48. doi: 10.1007/s10754-007-9013-z.

DOI:10.1007/s10754-007-9013-z
PMID:17638074
Abstract

Belgium has a mixed, public-private health care system, with state-organized reimbursements but private providers. The system is fee for service. For end-stage renal disease (ESRD), the fee-for-service system discourages preventive strategies, early referral to the nephrology unit, and the use of home-based therapies. The aging of the general population is reflected in the rapidly increasing number of very old dialysis patients, requiring more complicated and, therefore, more costly care. As dialysis costs increase, the ability to provide unrestricted access to dialysis treatment may be unsustainable. To aid in decision-making processes, nephrologists must be aware of financial and organizational issues.

摘要

比利时拥有公私混合的医疗保健系统,由国家组织报销,但医疗服务提供者为私立机构。该系统实行按服务收费。对于终末期肾病(ESRD),按服务收费系统不利于预防策略、早期转诊至肾病科以及家庭治疗的使用。老年人口的老龄化反映在高龄透析患者数量的迅速增加上,这需要更复杂、因此也更昂贵的护理。随着透析成本的增加,提供不受限制的透析治疗的能力可能难以为继。为了协助决策过程,肾病学家必须了解财务和组织问题。

相似文献

1
Belgium's mixed private/public health care system and its impact on the cost of end-stage renal disease.比利时公私混合的医疗保健系统及其对终末期肾病治疗费用的影响。
Int J Health Care Finance Econ. 2007 Sep;7(2-3):133-48. doi: 10.1007/s10754-007-9013-z.
2
The organization and financing of end-stage renal disease treatment in Japan.日本终末期肾病治疗的组织与资金筹集
Int J Health Care Finance Econ. 2007 Sep;7(2-3):217-31. doi: 10.1007/s10754-007-9017-8.
3
International Study of Health Care Organization and Financing for end-stage renal disease in France.法国终末期肾病医疗保健组织与融资的国际研究。
Int J Health Care Finance Econ. 2007 Sep;7(2-3):171-83. doi: 10.1007/s10754-007-9025-8.
4
International study of health care organization and financing: development of renal replacement therapy in Germany.国际医疗保健组织与融资研究:德国肾脏替代治疗的发展
Int J Health Care Finance Econ. 2007 Sep;7(2-3):185-200. doi: 10.1007/s10754-007-9020-0.
5
International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality.意大利肾脏替代治疗的医疗保健组织与融资国际研究:一个不断演变的现实。
Int J Health Care Finance Econ. 2007 Sep;7(2-3):201-15. doi: 10.1007/s10754-007-9016-9.
6
The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care.加拿大终末期肾病护理的经济学:激励措施及其对护理服务提供的影响。
Int J Health Care Finance Econ. 2007 Sep;7(2-3):149-69. doi: 10.1007/s10754-007-9022-y.
7
The financing and organization of medical care for patients with end-stage renal disease in Sweden.瑞典终末期肾病患者医疗护理的资金筹集与组织安排
Int J Health Care Finance Econ. 2007 Dec;7(4):269-81. doi: 10.1007/s10754-007-9014-y.
8
Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: access to ESRD treatments.医疗保健系统与终末期肾病(ESRD)治疗——一项国际综述:ESRD治疗的可及性
Nephrol Dial Transplant. 1999;14 Suppl 6:10-5. doi: 10.1093/ndt/14.suppl_6.10.
9
Appendix to dialysis centre guidelines: recommendations for the relationship between outpatient haemodialysis centres and reference hospitals. Opinions from the Outpatient Dialysis Group. Grupo de Trabajo de Hemodiálisis Extrahospitalaria.附录:透析中心指南:门诊血液透析中心与参考医院之间关系的建议。来自门诊透析组的意见。
Nefrologia. 2011;31(6):664-9. doi: 10.3265/Nefrologia.pre2011.Oct.11001.
10
End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).终末期肾病与经济激励措施:医疗保健组织与融资国际研究(ISHCOF)
Int J Health Care Finance Econ. 2007 Sep;7(2-3):73-111. doi: 10.1007/s10754-007-9024-9.

引用本文的文献

1
Landscape of kidney replacement therapy provision in low- and lower-middle income countries: A multinational study from the ISN-GKHA.低收入和中低收入国家肾脏替代治疗的现状:国际肾脏病学会-全球肾脏健康行动组织的一项多国研究
PLOS Glob Public Health. 2024 Dec 2;4(12):e0003979. doi: 10.1371/journal.pgph.0003979. eCollection 2024.
2
Capacity for the management of kidney failure in the International Society of Nephrology Western Europe region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).国际肾脏病学会西欧地区肾衰竭管理能力:来自2023年国际肾脏病学会全球肾脏健康地图集(ISN-GKHA)的报告。
Kidney Int Suppl (2011). 2024 Apr;13(1):136-151. doi: 10.1016/j.kisu.2024.01.008. Epub 2024 Apr 8.
3

本文引用的文献

1
The organization and funding of the treatment of end-stage renal disease in Australia.澳大利亚终末期肾病治疗的组织与资金筹集情况。
Int J Health Care Finance Econ. 2007 Sep;7(2-3):113-32. doi: 10.1007/s10754-007-9018-7.
2
International study of health care organization and financing: development of renal replacement therapy in Germany.国际医疗保健组织与融资研究:德国肾脏替代治疗的发展
Int J Health Care Finance Econ. 2007 Sep;7(2-3):185-200. doi: 10.1007/s10754-007-9020-0.
3
International Study of Health Care Organization and Financing for end-stage renal disease in France.
Early referral to nephrological care improves long-term survival and hospitalization after dialysis initiation, independent of optimal dialysis start - a call for harmonization of reimbursement policies.
早期转至肾脏科治疗可改善透析开始后的长期生存率和住院率,与最佳透析起始时间无关——呼吁协调报销政策。
Ren Fail. 2024 Dec;46(1):2313170. doi: 10.1080/0886022X.2024.2313170. Epub 2024 Feb 15.
4
Payment systems for dialysis and their effects: a scoping review.透析支付系统及其影响:范围综述。
BMC Health Serv Res. 2023 Jan 17;23(1):45. doi: 10.1186/s12913-022-08974-4.
5
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.降低慢性肾脏病的成本,同时提供优质的医疗保健:行动呼吁。
Nat Rev Nephrol. 2017 Jul;13(7):393-409. doi: 10.1038/nrneph.2017.63. Epub 2017 May 30.
6
Delivering Diabetes Education through Nurse-Led Telecoaching. Cost-Effectiveness Analysis.通过护士主导的远程辅导提供糖尿病教育。成本效益分析。
PLoS One. 2016 Oct 11;11(10):e0163997. doi: 10.1371/journal.pone.0163997. eCollection 2016.
7
A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events.评估法国终末期肾病肾脏替代治疗成本的综合方法:年龄、糖尿病状态和临床事件的重要性
Eur J Health Econ. 2017 May;18(4):459-469. doi: 10.1007/s10198-016-0801-6. Epub 2016 May 5.
8
A review of acute and chronic peritoneal dialysis in developing countries.发展中国家急性与慢性腹膜透析综述。
Clin Kidney J. 2015 Jun;8(3):310-7. doi: 10.1093/ckj/sfv029. Epub 2015 May 7.
9
Exploring the association between macroeconomic indicators and dialysis mortality.探讨宏观经济指标与透析患者死亡率之间的关联。
Clin J Am Soc Nephrol. 2012 Oct;7(10):1655-63. doi: 10.2215/CJN.10461011. Epub 2012 Jul 26.
10
Epidemiology of peritoneal dialysis: a story of believers and nonbelievers.腹膜透析的流行病学:信徒与非信徒的故事。
Nat Rev Nephrol. 2010 Feb;6(2):75-82. doi: 10.1038/nrneph.2009.210. Epub 2009 Dec 15.
法国终末期肾病医疗保健组织与融资的国际研究。
Int J Health Care Finance Econ. 2007 Sep;7(2-3):171-83. doi: 10.1007/s10754-007-9025-8.
4
The financing and organization of medical care for patients with end-stage renal disease in Sweden.瑞典终末期肾病患者医疗护理的资金筹集与组织安排
Int J Health Care Finance Econ. 2007 Dec;7(4):269-81. doi: 10.1007/s10754-007-9014-y.
5
International Study of Health Care Organization and Financing of renal services in England and Wales.英格兰和威尔士肾脏服务的医疗保健组织与融资国际研究
Int J Health Care Finance Econ. 2007 Dec;7(4):283-99. doi: 10.1007/s10754-007-9015-x.
6
International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality.意大利肾脏替代治疗的医疗保健组织与融资国际研究:一个不断演变的现实。
Int J Health Care Finance Econ. 2007 Sep;7(2-3):201-15. doi: 10.1007/s10754-007-9016-9.
7
The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care.加拿大终末期肾病护理的经济学:激励措施及其对护理服务提供的影响。
Int J Health Care Finance Econ. 2007 Sep;7(2-3):149-69. doi: 10.1007/s10754-007-9022-y.
8
The organization and financing of dialysis and kidney transplantation services in New Zealand.新西兰透析和肾移植服务的组织与资金筹措
Int J Health Care Finance Econ. 2007 Dec;7(4):233-52. doi: 10.1007/s10754-007-9023-x.
9
The organization and financing of kidney dialysis and transplant care in the United States of America.美利坚合众国肾脏透析及移植护理的组织与资金筹集情况。
Int J Health Care Finance Econ. 2007 Dec;7(4):301-18. doi: 10.1007/s10754-007-9019-6.
10
The organization and financing of end-stage renal disease in Spain.西班牙终末期肾病的组织与融资
Int J Health Care Finance Econ. 2007 Dec;7(4):253-67. doi: 10.1007/s10754-007-9021-z.